Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -30.972\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a CC(=O)Nc1cccc(N(C)S(C)(=O)=O)c1
b COc1ccc(-c2cc(C(=O)NN)n(-c3ccccc3)n2)cc1
c COc1ccc(C2C3=C(CC(C)(C)CC3=O)Oc3ncn(CC(C)C)c(=N)c32)cc1
d CCOc1ccc(NC(=O)Nc2cc(C)ccc2OC)cc1
e COc1ccc(C(=O)c2ccccc2Cl)cc1
Answer: c. COc1ccc(C2C3=C(CC(C)(C)CC3=O)Oc3ncn(CC(C)C)c(=N)c32)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
4-imino-5-(4-methoxyphenyl)-8,8-dimethyl-3-(2-methylpropyl)-7,9-dihydro-5H-chromeno[2,3-d]pyrimidin-6-one